UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Celltrion unveils clinical results of Remsima SC in treating IBD
Celltrion said that is has presented the phase 1, part 2 trial results for ...
by Lee Han-soo
|
2019-10-22 17:00
라인
KUGH’s emergency treatment system saved Frenchman
Korea University Guro Hospital (KUGH) said that its emergency medical syste...
by Lee Han-soo
|
2019-10-22 15:45
라인
Biogen, Samsung Bioepis to present biosimilar data at EU conference
Biogen and Samsung Bioepis said that they plan to present new real-world da...
by Lee Han-soo
|
2019-10-22 11:31
라인
Vuno, EU to develop AI software that predicts antidepressant efficacy
Vuno said that it would develop DEPREDICT, an artificial intelligence softw...
by Lee Han-soo
|
2019-10-22 11:31
라인
Pharma industry hits government steps regarding ranitidine ban
The local pharmaceutical industry is expressing its distrust and displeasur...
by Lee Han-soo
|
2019-10-21 17:16
라인
GSK applies for additional indication of asthma inhaler Trelegy Ellipta
GSK said that it has applied to obtain an additional indication for Trelegy...
by Lee Han-soo
|
2019-10-21 15:32
라인
Korea University Medicine to supply public healthcare service to Uzbekistan
Korea University Medicine (KUM) said that it would develop and supply the K...
by Lee Han-soo
|
2019-10-21 14:24
라인
Regulator OKs Jeil's advanced colorectal cancer treatment
Jeil Pharmaceutical said that the Ministry of Food and Drug Safety has appr...
by Lee Han-soo
|
2019-10-21 11:38
라인
‘Government says one thing, does another on bio-health industry promotion’
President Moon Jae-in has pledged to foster the bio-health industry as a ma...
by Lee Han-soo
|
2019-10-21 11:38
라인
Ministry OKs ATGC's p1, 2 trial for BTX
ATGC, a local biopharmaceutical firm, said that the Ministry of Food and Dr...
by Lee Han-soo
|
2019-10-18 18:23
라인
Physicians feel burdened by Ranitidine ban: survey
Nearly half of doctors have encountered difficulties with patients over the...
by Lee Han-soo
|
2019-10-18 16:48
라인
Daewoong launches BTX in Canada
Daewoong Pharmaceutical said that it has launched its botulinum toxin (BTX)...
by Lee Han-soo
|
2019-10-18 14:31
라인
[Startups to Watch] 'Vuno puts doctors’ needs ahead of marketability in developing products’
The rise of artificial intelligence (AI) has thrown pharmaceutical companie...
by Lee Han-soo
|
2019-10-18 12:21
라인
Severance researchers find intestinal inflammatory inhibition gene
Researchers at Severance Hospital have discovered RORα, a new gene th...
by Lee Han-soo
|
2019-10-17 18:00
라인
CHA Biotech wins patent for somatic-cloned embryonic stem cell tech
CHA Biotech said it has registered a patent for the method of manufacturing...
by Lee Han-soo
|
2019-10-17 17:59
라인
‘Inventage Lab’s hair loss injection more convenient than oral drugs’
Researchers at Chung-Ang University Hospital have confirmed the efficacy of...
by Lee Han-soo
|
2019-10-17 14:48
라인
'Eisai's Lenvima extends survival period, improves patients’ quality of life'
Eisai's Lenvima, a hepatocellular carcinoma treatment, has managed to s...
by Lee Han-soo
|
2019-10-16 18:22
라인
‘New drug approval process takes about 300 days in Korea’
A local research team has found that it takes about 300 days for multinatio...
by Lee Han-soo
|
2019-10-16 15:06
라인
Eulji Medical Center transfers advanced medical expertise to Bangladesh
Eulji Medical Center (EMC) said Wednesday that it would provide invitation ...
by Lee Han-soo
|
2019-10-16 11:28
라인
Seoul Medical Center transfer public healthcare know-how to developing countries
Seoul Medical Center (SMC) is speeding up the transfer of "Seoul-model publ...
by Lee Han-soo
|
2019-10-15 18:02
-
이전
31
32
33
34
35
36
37
38
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top